Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats

Neurosci Lett. 2004 Oct 14;369(2):138-41. doi: 10.1016/j.neulet.2004.07.086.

Abstract

The present study investigates the neuroprotective effects of midkine (MK) and retinoic acid (RA) against ischemia in the CNS. Primary cortical neurons, derived from rat E15 embryos (DIV9), were treated with 9-cis-RA (9cRA), all-trans-RA (atRA) or vehicle. Using quantitative PCR, the level of MK mRNA was significantly increased at 4h after 9cRA application. The protective effect of RA and MK was also investigated in adult Sprague-Dawley rats. 9cRA, atRA, MK, or vehicle was injected into the lateral ventricle prior to a 60-min-MCA ligation. Pretreatment with 9cRA or MK attenuated cerebral infarction in stroke animals. Application of a similar dose of atRA did not reduce the size of infarction. In conclusion, our data suggest that 9cRA has neuroprotective effects against ischemia-related brain injury which may involve upregulation of midkine.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alitretinoin
  • Analysis of Variance
  • Animals
  • Blood Gas Analysis / methods
  • Blood Pressure / drug effects
  • Body Temperature / drug effects
  • Cells, Cultured
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cerebral Infarction / etiology
  • Cerebral Infarction / pathology
  • Cerebral Infarction / prevention & control*
  • Cytokines / genetics
  • Cytokines / therapeutic use*
  • Embryo, Mammalian
  • Infarction, Middle Cerebral Artery / complications*
  • Infarction, Middle Cerebral Artery / pathology
  • Male
  • Midkine
  • RNA, Messenger / biosynthesis
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Tetrazolium Salts
  • Tretinoin / pharmacology
  • Tretinoin / therapeutic use*

Substances

  • Cytokines
  • RNA, Messenger
  • Tetrazolium Salts
  • Midkine
  • Alitretinoin
  • Tretinoin
  • triphenyltetrazolium